By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Life Technologies said on Friday it intends to redeem all of the outstanding 1.5 percent convertible senior notes due 2024.

The company intends to redeem the all of the notes on Feb. 15, and said that as of Dec. 31, 2011, $450 million in aggregate principal amount of the notes were outstanding. The notes are convertible prior to Feb. 14, 5 p.m. EST at a rate of 19.603 shares of common stock for each $1,000 principal amount of the notes surrendered.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

With the launch of Scott Kelly into space today, the study of him and his earthbound brother to disentangle the effects of life in space from the effects of genetics kicks off.

In Science this week: self-assembly of DNA components in solution, and more.

Genetics and Molecular Research retracts two gastric cancer papers for being "substantially equal" to other papers, according to Retraction Watch.

A new analysis indicates that the Ebola virus behind the current West African outbreak is mutating at about the same rate as other Ebola viruses.